Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-08

Clinical Trial Update: Effect of Dexmedetomidine on Postoperative Delirium Inflammasome Activation Inhibition [NA]

View source ↗

Summary

A clinical trial evaluating whether dexmedetomidine modulates postoperative delirium by inhibiting inflammasome activation in patients undergoing hip, femur, or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Yonsei University | Conditions: Patients Under Hip, Femur, Spine Operation | NA | Status: UNKNOWN